ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 223 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,218,761 | +0.6% | 92,752 | -3.5% | 0.01% | +9.1% |
Q2 2023 | $1,211,616 | -5.2% | 96,160 | -1.9% | 0.01% | -15.4% |
Q1 2023 | $1,278,704 | +98565.4% | 97,985 | +33.4% | 0.01% | -35.0% |
Q4 2022 | $1,296 | -99.9% | 73,454 | -7.8% | 0.02% | +5.3% |
Q3 2022 | $1,214,000 | -3.3% | 79,682 | -5.8% | 0.02% | -5.0% |
Q2 2022 | $1,255,000 | -35.9% | 84,625 | -2.6% | 0.02% | -25.9% |
Q1 2022 | $1,957,000 | +20.1% | 86,898 | -1.7% | 0.03% | +35.0% |
Q4 2021 | $1,630,000 | +31.9% | 88,361 | -4.4% | 0.02% | +33.3% |
Q3 2021 | $1,236,000 | -36.5% | 92,475 | -12.1% | 0.02% | -34.8% |
Q2 2021 | $1,947,000 | +23.9% | 105,200 | +0.6% | 0.02% | +21.1% |
Q1 2021 | $1,571,000 | -14.2% | 104,617 | -17.5% | 0.02% | -17.4% |
Q4 2020 | $1,832,000 | +47.9% | 126,852 | -16.7% | 0.02% | +35.3% |
Q3 2020 | $1,239,000 | +42.6% | 152,247 | +18.5% | 0.02% | +21.4% |
Q2 2020 | $869,000 | -10.8% | 128,428 | -7.1% | 0.01% | -22.2% |
Q1 2020 | $974,000 | -10.6% | 138,283 | +24.5% | 0.02% | +5.9% |
Q4 2019 | $1,090,000 | -12.4% | 111,060 | -2.1% | 0.02% | -15.0% |
Q3 2019 | $1,245,000 | -5.3% | 113,430 | +0.4% | 0.02% | 0.0% |
Q2 2019 | $1,314,000 | +18.4% | 112,957 | -2.9% | 0.02% | +11.1% |
Q1 2019 | $1,110,000 | +0.7% | 116,332 | +1.8% | 0.02% | -5.3% |
Q4 2018 | $1,102,000 | -29.6% | 114,331 | +4.1% | 0.02% | -13.6% |
Q3 2018 | $1,566,000 | +13.6% | 109,865 | -4.3% | 0.02% | +15.8% |
Q2 2018 | $1,378,000 | -6.8% | 114,853 | -4.1% | 0.02% | -5.0% |
Q1 2018 | $1,479,000 | -16.8% | 119,725 | -2.0% | 0.02% | -9.1% |
Q4 2017 | $1,777,000 | -5.3% | 122,135 | -7.4% | 0.02% | -8.3% |
Q3 2017 | $1,876,000 | +10.9% | 131,855 | -0.5% | 0.02% | +9.1% |
Q2 2017 | $1,691,000 | +2.1% | 132,489 | +1.4% | 0.02% | 0.0% |
Q1 2017 | $1,657,000 | +20.2% | 130,693 | -3.2% | 0.02% | +22.2% |
Q4 2016 | $1,378,000 | -26.4% | 134,995 | -5.0% | 0.02% | -28.0% |
Q3 2016 | $1,872,000 | +3.0% | 142,119 | -0.6% | 0.02% | +4.2% |
Q2 2016 | $1,817,000 | -9.1% | 143,039 | -5.4% | 0.02% | -4.0% |
Q1 2016 | $1,998,000 | -17.1% | 151,265 | -3.5% | 0.02% | -16.7% |
Q4 2015 | $2,410,000 | +24.4% | 156,721 | +0.4% | 0.03% | +20.0% |
Q3 2015 | $1,937,000 | -2.1% | 156,173 | +8.0% | 0.02% | +8.7% |
Q2 2015 | $1,979,000 | +8.3% | 144,645 | -5.4% | 0.02% | +15.0% |
Q1 2015 | $1,828,000 | -6.2% | 152,834 | +0.2% | 0.02% | -4.8% |
Q4 2014 | $1,948,000 | -5.4% | 152,547 | -0.7% | 0.02% | -8.7% |
Q3 2014 | $2,060,000 | -20.5% | 153,577 | -4.9% | 0.02% | -14.8% |
Q2 2014 | $2,592,000 | -10.6% | 161,495 | +0.4% | 0.03% | -10.0% |
Q1 2014 | $2,900,000 | +12.2% | 160,851 | -3.7% | 0.03% | +15.4% |
Q4 2013 | $2,584,000 | +3.6% | 167,110 | -0.4% | 0.03% | 0.0% |
Q3 2013 | $2,495,000 | -3.0% | 167,809 | -15.6% | 0.03% | -3.7% |
Q2 2013 | $2,572,000 | -2.3% | 198,768 | +2.6% | 0.03% | 0.0% |
Q1 2013 | $2,633,000 | – | 193,760 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |